Adverse event reports following vaccination for Lyme disease: December 1998-July 2000

Vaccine

Volumn 20, Issue 11-12, 2002, Pages 1603-1608

  Lathrop, Sarah L ^a   Ball, Robert ^d   Haber, Penina ^c   Mootrey, Gina T ^c   Braun, M Miles ^d   Shadomy, Sean V ^d   Ellenberg, Susan S ^d   Chen, Robert T ^c   Hayes, Edward B ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c CENTERS FOR DIS CONTR AND PREV   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Adverse events; Lyme disease; Lyme vaccine; Major histocompatibility complex; Safety; Vaccine adverse event reporting system

Indexed keywords

LYME DISEASE VACCINE;

ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; ASTHENIA; CAUSE OF DEATH; CONTROLLED STUDY; DRUG SAFETY; FACIAL NERVE PARALYSIS; FEMALE; FEVER; FLU LIKE SYNDROME; HEADACHE; HOSPITALIZATION; HUMAN; HYPERSENSITIVITY REACTION; INJECTION PAIN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; MYALGIA; OSTEOARTHRITIS; PAIN; PRIORITY JOURNAL; RASH; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SIDE EFFECT; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRALGIA; CHILD; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; LYME DISEASE VACCINES; MALE; MIDDLE AGED; PAIN; PRODUCT SURVEILLANCE, POSTMARKETING; SAFETY; TIME FACTORS; UNITED STATES;

EID: 0037154759     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00500-X     Document Type: Article

References (15)

1. Recommendations for the use of Lyme disease vaccine
2. Borrelia burgdorferi rOspA is an arthropod-specific transmission-blocking Lyme disease vaccine
3. Influence of outer surface protein A antibody on Borrelia burgdorferi within feeding ticks
4. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant
5. Treatment of Lyme arthritis
6. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi
7. Descriptive epidemiology of adverse events after immunization: Reports to the vaccine adverse event reporting system (VAERS), 1991-1994
8. The vaccine adverse event reporting system (VAERS)
9. The complicated task of monitoring vaccine safety
10. An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system
11. The facial nerve
12. The reporting sensitivities of two passive surveillance systems for vaccine adverse events
13. Impact of arthritis and other rheumatic conditions on the health-care system-United States, 1997